Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Total 13F shares
-
498,312
-
Share change
-
+281,120
-
Total reported value
-
$597,000
-
Price per share
-
$1.20
-
Number of holders
-
15
-
Value change
-
+$332,841
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q1 2020
As of 31 Mar 2020 CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 498,312 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Coastal Bridge Advisors, LLC, ACADIAN ASSET MANAGEMENT LLC, US BANCORP \DE\, and MORGAN STANLEY.
This table shows 15 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.